Balyasny Asset Management
LHDX

Balyasny Asset Management’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Balyasny Asset Management’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-271,030
Closed -$30.1K – 3428
2022
Q4 		$30.1K Sell
271,030
-55,168
-17% -$35.2K ﹤0.01% 2422
2022
Q3 		$346K Hold
326,198
– – ﹤0.01% 2150
2022
Q2 		$607K Buy
+326,198
New +$793K ﹤0.01% 1919
2021
Q4 		– Sell
-93,439
Closed -$710K – 2800
2021
Q3 		$710K Buy
93,439
+57,224
+158% +$483K ﹤0.01% 1410
2021
Q2 		$240K Sell
36,215
-64,393
-64% -$406K ﹤0.01% 1694
2021
Q1 		$1.22M Buy
+100,608
New +$2M 0.01% 1183

Other funds holding LHDX

EV
Eclipse Ventures Palo Alto, California $39.6M AUM
Simplex Trading
Simplex Trading Chicago, Illinois $3.23B AUM 62.07% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $18.6B AUM 29.12% 1-Year Est. Return
RA
Resolute Advisors San Francisco, California $242M AUM 52.95% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
CS
Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return